<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01866215</url>
  </required_header>
  <id_info>
    <org_study_id>University of Lausanne</org_study_id>
    <nct_id>NCT01866215</nct_id>
  </id_info>
  <brief_title>Effects of Exercise on Fructose Metabolism</brief_title>
  <acronym>FruEx2</acronym>
  <official_title>Effects of Exercise on Fructose Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in
      sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic
      de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced
      dyslipidemia.This study will evaluate

        1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed
           before fructose ingestion 1b) when exercise is performed after fructose ingestion
           Metabolic effects of exercise will be assessed in healthy male subjects by measuring
           fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose
           concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very
           low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled
           fructose meals

        2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion
           after exercise Healthy male subjects will be fed various fructose, glucose, lipid and
           whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The
           effects of meals' composition will be assessed after 24 hours by measuring
           intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma triglyceride</measure>
    <time_frame>measurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)</time_frame>
    <description>measurement of total and VLDL-TG concentrations in study 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intramyocellular lipids</measure>
    <time_frame>after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise</time_frame>
    <description>Measurement by 1H-MRS in muscle vastus lateralis in study 2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fructose conversion into lipids</measure>
    <time_frame>measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)</time_frame>
    <description>Estimated from 13C palmitate-VLDL concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fructose conversion into glucose</measure>
    <time_frame>measured between 7:00 am and 4:oo pm (up to 9 hours)</time_frame>
    <description>measurements obtained from plasma 13C glucose concentrations and whole body glucose production measured by 6,6 d2 glucose in study 1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intramyocellular glycogen concentrations</measure>
    <time_frame>after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise</time_frame>
    <description>Measured by 1H-MRS in muscle vastus lateralis in study 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fructose oxidation</measure>
    <time_frame>measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)</time_frame>
    <description>Calculated from breath 13CO2 production</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exogenous lipid oxidation</measure>
    <time_frame>measured from 7:00 am to 4:00 pm in study 2 (up to 9 hours)</time_frame>
    <description>Lipids ingested will be labeled with 13C-triolein, and exogenous lipid oxidation will be measured from breath 13CO2 production</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Study1a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercice performed 90 min before 13C fructose meal ingestion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 1b</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercise performed 90 min after 13C fructose meal ingestion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 1c</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 2a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>meals containing fructose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 2b</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>meals containing glucose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>cycling at 100W during 60 min</description>
    <arm_group_label>Study1a</arm_group_label>
    <arm_group_label>study 1b</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fructose</intervention_name>
    <description>isocaloric nutrition with fructose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise</description>
    <arm_group_label>study 2a</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>glucose</intervention_name>
    <description>isocaloric nutrition with glucose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise</description>
    <arm_group_label>study 2b</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males

          -  18-40 years old

          -  19 kg/m2&gt;BMI&gt;25kg/m2

          -  moderate to high usual physical activity

          -  non-smokers

        Exclusion Criteria:

          -  family history of diabetes mellitus

          -  ECG anomaly

          -  any medication

          -  participation to blood spending or other clinical study in the 3 months before the
             beginning of this study

          -  consumption of drugs

          -  consumption of more than 50g alcool/week

          -  family history of food intolerance
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Tappy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2013</study_first_submitted>
  <study_first_submitted_qc>May 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2013</study_first_posted>
  <last_update_submitted>June 3, 2014</last_update_submitted>
  <last_update_submitted_qc>June 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor of Physiology</investigator_title>
  </responsible_party>
  <keyword>gluconeogenesis</keyword>
  <keyword>de novo lipogenesis</keyword>
  <keyword>intramyocellular lipids</keyword>
  <keyword>muscle glycogen</keyword>
  <keyword>fructose</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

